Keros Therapeutics, Inc. · NASDAQ:KROS
Keros Therapeutics, Inc. shareholders
As of Sep 30, 2026, 130 institutions reported holding Keros Therapeutics, Inc., 95.0% of its shares. Largest: BlackRock, Vanguard and Nantahala Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Keros Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 3.5M | 17.8% | +707K | Nov 13, 2026 |
| Vanguard | 1.61M | 8.2% | −14,767 | Nov 13, 2026 |
| Nantahala Capital Management, LLC | 1.49M | 7.6% | −1.33M | Nov 13, 2026 |
| AQR Capital Management LLC | 804K | 4.1% | −164K | Nov 16, 2026 |
| Orbimed Advisors LLC | 759K | 3.9% | no change | Nov 16, 2026 |
| Mackenzie | 743K | 3.8% | +114K | Nov 2, 2026 |
| Federated Hermes, Inc. | 707K | 3.6% | +6,627 | Nov 12, 2026 |
| Madison Avenue Partners, LP | 627K | 3.2% | no change | Nov 16, 2026 |
| Two Sigma | 548K | 2.8% | +301K | Nov 16, 2026 |
| State Street | 542K | 2.8% | +405 | Nov 12, 2026 |